WO2007066181A3 - Methods of preparing a vegf-r inhibitor - Google Patents
Methods of preparing a vegf-r inhibitor Download PDFInfo
- Publication number
- WO2007066181A3 WO2007066181A3 PCT/IB2006/003331 IB2006003331W WO2007066181A3 WO 2007066181 A3 WO2007066181 A3 WO 2007066181A3 IB 2006003331 W IB2006003331 W IB 2006003331W WO 2007066181 A3 WO2007066181 A3 WO 2007066181A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inhibitor
- preparing
- methods
- vegf
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to methods for preparing a compound of formula (7), which is useful as a modulator and/or inhibitor of protein kinases. The present invention also relates to intermediate compounds useful in the preparation of a compound of formula (7).
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06820962A EP1963310A2 (en) | 2005-12-05 | 2006-11-20 | Methods of preparing a vegf-r inhibitor |
CA002632384A CA2632384A1 (en) | 2005-12-05 | 2006-11-20 | Methods of preparing a vegf-r inhibitor |
JP2008543930A JP2009518382A (en) | 2005-12-05 | 2006-11-20 | Methods for preparing VEGF-R inhibitors |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74284705P | 2005-12-05 | 2005-12-05 | |
US60/742,847 | 2005-12-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007066181A2 WO2007066181A2 (en) | 2007-06-14 |
WO2007066181A3 true WO2007066181A3 (en) | 2007-10-04 |
Family
ID=37857108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/003331 WO2007066181A2 (en) | 2005-12-05 | 2006-11-20 | Methods of preparing a vegf-r inhibitor |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1963310A2 (en) |
JP (1) | JP2009518382A (en) |
CA (1) | CA2632384A1 (en) |
WO (1) | WO2007066181A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7829574B2 (en) | 2008-05-09 | 2010-11-09 | Hutchison Medipharma Enterprises Limited | Substituted quinazoline compounds and their use in treating angiogenesis-related diseases |
JP6315708B2 (en) * | 2015-06-22 | 2018-04-25 | 日本電信電話株式会社 | Lithium-air secondary battery, method for producing lithium-air secondary battery, and apparatus equipped with lithium-air secondary battery |
CN112724110B (en) * | 2021-01-13 | 2021-10-26 | 广州安岩仁医药科技有限公司 | Synthesis method of VEGFR inhibitor furoquintinib and benzofuran intermediate thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050137395A1 (en) * | 2003-12-23 | 2005-06-23 | Agouron Pharmaceuticals, Inc. | Novel quinoline derivatives |
-
2006
- 2006-11-20 CA CA002632384A patent/CA2632384A1/en not_active Abandoned
- 2006-11-20 JP JP2008543930A patent/JP2009518382A/en active Pending
- 2006-11-20 WO PCT/IB2006/003331 patent/WO2007066181A2/en active Application Filing
- 2006-11-20 EP EP06820962A patent/EP1963310A2/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050137395A1 (en) * | 2003-12-23 | 2005-06-23 | Agouron Pharmaceuticals, Inc. | Novel quinoline derivatives |
Also Published As
Publication number | Publication date |
---|---|
CA2632384A1 (en) | 2007-06-14 |
EP1963310A2 (en) | 2008-09-03 |
WO2007066181A2 (en) | 2007-06-14 |
JP2009518382A (en) | 2009-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007019191A3 (en) | Thiazolopyrimidine kinase inhibitors | |
WO2006062984A3 (en) | Inhibitors of protein kinases | |
WO2009018909A3 (en) | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors | |
WO2007067472A3 (en) | Novel complex for use in stabilizing herbicidal compositions and methods for synthesizing and using the same | |
WO2005108358A3 (en) | Pyrrolidine derivatives useful as bace inhibitors | |
WO2003093269A3 (en) | Substituted pyrazolo-pyrimidine-4-ones | |
WO2006069363A3 (en) | Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride | |
WO2007085895A3 (en) | Fap inhibitors | |
WO2007079164A3 (en) | Protein kinase inhibitors | |
WO2008039359A3 (en) | Bicyclic pyrimidine kinase inhibitors | |
WO2007105058A8 (en) | Pyrazole compounds | |
WO2006123113A3 (en) | Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors | |
WO2004096234A3 (en) | Kinase inhibitor phosphonate conjugates | |
WO2006050109A3 (en) | Novel kinase inhibitors | |
SG170729A1 (en) | Processes and intermediates for preparing steric compounds | |
WO2006122216A3 (en) | Processes for production of phenolic 4-biphenylylazetidin-2-ones | |
WO2006062982A3 (en) | Urea inhibitors of map kinases | |
WO2005021536A3 (en) | Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors | |
WO2008061108A3 (en) | Phthalazine derivatives | |
WO2006052568A3 (en) | Tgf-beta inhibitors | |
TW200621721A (en) | Methods of preparing indazole compounds | |
WO2008046919A3 (en) | Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors | |
WO2005076990A3 (en) | Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors | |
UA96759C2 (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
WO2007081690A3 (en) | Inhibitors of protein kinases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2632384 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008543930 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006820962 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2006820962 Country of ref document: EP |